Study: Drug sales may not benefit from ads directed to patients
USA Today, September 2, 2008
Spending on direct-to-consumer advertising of prescription drugs continues to rise, but a new study suggests it might not be worth the cost. Drug companies spent an estimated $4.24 billion on direct-to-consumer ads in 2005, more than triple what they spent in 1996. But it was still far less than what they spend on marketing to doctors, researchers report.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- Proton Beam Therapy Poised for Growth in US